Sentinel lymph node mapping and staging in endometrial cancer: a Society of Gynecologic Oncology literature review with consensus recommendations
RW Holloway, NR Abu-Rustum, FJ Backes… - Gynecologic …, 2017 - Elsevier
The emphasis in contemporary medical oncology has been “precision” or “personalized”
medicine, terms that imply a strategy to improve efficacy through targeted therapies. Similar …
medicine, terms that imply a strategy to improve efficacy through targeted therapies. Similar …
Outcome of fertility-sparing treatment with progestins in young patients with endometrial cancer
WH Gotlieb, ME Beiner, B Shalmon, Y Korach… - Obstetrics & …, 2003 - Elsevier
OBJECTIVE: To evaluate the safety of fertility-sparing hormonal therapy for endometrial
cancer in young patients. METHODS: We reviewed the clinical and pathologic records of …
cancer in young patients. METHODS: We reviewed the clinical and pathologic records of …
Sentinel lymph node biopsy in high-grade endometrial cancer: a systematic review and meta-analysis of performance characteristics
Z Marchocki, MC Cusimano, L Clarfield, SR Kim… - American journal of …, 2021 - Elsevier
Objective A sentinel lymph node biopsy is widely accepted as the standard of care for
surgical staging in low-grade endometrial cancer, but its value in high-grade endometrial …
surgical staging in low-grade endometrial cancer, but its value in high-grade endometrial …
[HTML][HTML] Phase II study of temsirolimus in women with recurrent or metastatic endometrial cancer: a trial of the NCIC Clinical Trials Group
Purpose Phosphatase and tensin homolog (PTEN) is a tumor suppressor gene, and loss of
function mutations are common and appear to be important in the pathogenesis of …
function mutations are common and appear to be important in the pathogenesis of …
In vitro metformin anti-neoplastic activity in epithelial ovarian cancer
WH Gotlieb, J Saumet, MC Beauchamp, J Gu, S Lau… - Gynecologic …, 2008 - Elsevier
OBJECTIVE: Metformin, a commonly used drug in the treatment of type II diabetes, may
reduce cancer risk and improve cancer prognosis. We evaluated its effect on epithelial …
reduce cancer risk and improve cancer prognosis. We evaluated its effect on epithelial …
High levels of MMP-2, MMP-9, MT1-MMP and TIMP-2 mRNA correlate with poor survival in ovarian carcinoma
B Davidson, I Goldberg, WH Gotlieb… - Clinical & experimental …, 1999 - Springer
The object of this study was to analyze the potential association between the expression of
MMP-2, MMP-9, MT1-MMP and TIMP-2, and disease outcome in advanced-stage ovarian …
MMP-2, MMP-9, MT1-MMP and TIMP-2, and disease outcome in advanced-stage ovarian …
Intravenous aflibercept for treatment of recurrent symptomatic malignant ascites in patients with advanced ovarian cancer: a phase 2, randomised, double-blind …
WH Gotlieb, F Amant, S Advani, C Goswami… - The lancet …, 2012 - thelancet.com
Background Targeting of VEGF is a potential therapeutic option in patients with malignant
ovarian ascites. We present the final results of a multicentre study of the efficacy and safety …
ovarian ascites. We present the final results of a multicentre study of the efficacy and safety …
Recurrence rates in patients with cervical cancer treated with abdominal versus minimally invasive radical hysterectomy: a multi-institutional retrospective review study
PURPOSE To compare the disease-free survival (DFS) between open and minimally
invasive radical hysterectomies (RH) performed in academic medical institutions METHODS …
invasive radical hysterectomies (RH) performed in academic medical institutions METHODS …
Induction of apoptosis by metformin in epithelial ovarian cancer: involvement of the Bcl-2 family proteins
A Yasmeen, MC Beauchamp, E Piura, E Segal… - Gynecologic …, 2011 - Elsevier
OBJECTIVE: The aims of the study were to evaluate the ability of metformin to induce
apoptosis in epithelial ovarian cancer cell lines and to identify the pathways involved in this …
apoptosis in epithelial ovarian cancer cell lines and to identify the pathways involved in this …
Borderline tumors of the ovary: fertility treatment, conservative management, and pregnancy outcome
WH Gotlieb, S Flikker, B Davidson… - … Journal of the …, 1998 - Wiley Online Library
BACKGROUND Ovarian tumors of borderline malignancy have a less aggressive behavior
and tend to occur at a younger age than their invasive counterparts. The role and extent of …
and tend to occur at a younger age than their invasive counterparts. The role and extent of …